HR 1922 · in committee · significant
Ensuring Access to Essential Drugs Act
- healthcare
What this bill does
- The bill exempts certain brand-name drugs from Medicare's requirement that manufacturers provide discounts to beneficiaries.
- Medicare Part D prescription drug beneficiaries who have exceeded their annual deductible are affected.
- The exemption applies only to oral brand-name drugs that qualify as generics under Medicaid rules.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would exempting certain brand-name drugs from Medicare discounts affect out-of-pocket costs for seniors who rely on those specific medications?
- 02
What criteria should determine which oral brand-name drugs qualify for this exemption, and who decides if those criteria are appropriate?
- 03
How might this exemption change pharmaceutical manufacturers' incentives to develop generic alternatives compared to current Medicare discount requirements?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-NY-2
Andrew R. Garbarino
Citizen cosponsors
0
In Congress
2/ 435
House Reps cosponsoring
Introduced 2025-03-06
Joining the bill
Legislative timeline
2025-03-06 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-03-06 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-03-06 · IntroReferral
Introduced in House
2025-03-06 · IntroReferral
Introduced in House
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.